GlassScriptPhysician profile
Jerald P Vizzone
NPI 1861617623
$9,928.34
in general payments reported to CMS, 2019-2025
15 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,534 · 2020: $43.95 · 2021: $5,979 · 2022: $1,898 · 2023: $85.31 · 2024: $97.42 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $4,204.74 | 2021-2022 | |
| Integrity Implants INC. | $1,763.76 | 2021 | |
| Hydrocision, INC. | $1,250.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $1,232.65 | 2019 | |
| Nuvasive, INC. | $414.69 | 2020-2022 | |
| Smith+Nephew, INC. | $346.56 | 2019-2024 | Lens 4k, N/A |
| Alphatec Spine, INC | $271.54 | 2025 | Identiti |
| Surgalign Spine Technologies, INC. | $100.00 | 2019 | |
| Seapearl East, INC | $98.76 | 2023-2024 | |
| Horizon Therapeutics Plc | $92.86 | 2020-2023 | Krystexxa |
| Stryker Corporation | $46.81 | 2022 | |
| Providence Medical Technology, INC. | $43.88 | 2022 | |
| Life Spine, INC. | $26.08 | 2023 | Prolift Micro |
| Djo, LLC | $18.70 | 2025 | Cmf |
| Zimvie INC. | $17.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerald Vizzone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.